On March 21, 2019, leading Alzheimer’s researchers, government officials, biopharmaceutical industry executives and patient advocates from across the globe met at the University of Tokyo for the second annual Alzheimer’s Asian Scientific Roundtable. The meeting was convened by the University of Tokyo, Health and Global Policy Institute, The Global CEO Initiative on Alzheimer’s Disease (CEOi), and ResearchersAgainstAlzheimer’s, a global network of UsAgainstAlzheimer’s.

In “A Consensus Statement & Research Framework”, with unanimous support, the convening organizations and participants call on Japan’s Prime Minister Shinzo Abe to leverage his platform and Presidency of the G20 in 2019 to articulate a vision for addressing Alzheimer’s disease and dementia and urge him to lead the global public health response on the issue.